HomeIDIA • SWX
add
Idorsia Ltd
Previous close
CHF 2.79
Day range
CHF 2.56 - CHF 2.85
Year range
CHF 0.61 - CHF 3.63
Market cap
602.73M CHF
Avg Volume
1.71M
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Financials
Income Statement
Revenue
Net income
| (CHF) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 72.24M | 341.89% |
Operating expense | 48.44M | -33.20% |
Net income | -11.38M | 89.52% |
Net profit margin | -15.75 | 97.63% |
Earnings per share | — | — |
EBITDA | 2.70M | 102.97% |
Effective tax rate | -48.21% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 83.26M | -66.43% |
Total assets | 498.01M | -25.68% |
Total liabilities | 1.64B | -4.26% |
Total equity | -1.14B | — |
Shares outstanding | 204.09M | — |
Price to book | -0.50 | — |
Return on assets | -1.17% | — |
Return on capital | -3.96% | — |
Cash Flow
Net change in cash
| (CHF) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -11.38M | 89.52% |
Cash from operations | -35.26M | 63.73% |
Cash from investing | -9.73M | -3,643.46% |
Cash from financing | 67.04M | 83,898.75% |
Net change in cash | 21.39M | 121.90% |
Free cash flow | -36.46M | 52.36% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
938
